242 related articles for article (PubMed ID: 32104684)
21. NLRC5 mediates cell proliferation, migration, and invasion by regulating the Wnt/β-catenin signalling pathway in clear cell renal cell carcinoma.
Wang Q; Ding H; He Y; Li X; Cheng Y; Xu Q; Yang Y; Liao G; Meng X; Huang C; Li J
Cancer Lett; 2019 Mar; 444():9-19. PubMed ID: 30543814
[TBL] [Abstract][Full Text] [Related]
22. Loss of Porcupine impairs convergent extension during gastrulation in zebrafish.
Chen Q; Takada R; Takada S
J Cell Sci; 2012 May; 125(Pt 9):2224-34. PubMed ID: 22357957
[TBL] [Abstract][Full Text] [Related]
23. Genistein downregulates onco-miR-1260b and inhibits Wnt-signalling in renal cancer cells.
Hirata H; Ueno K; Nakajima K; Tabatabai ZL; Hinoda Y; Ishii N; Dahiya R
Br J Cancer; 2013 May; 108(10):2070-8. PubMed ID: 23591200
[TBL] [Abstract][Full Text] [Related]
24. LINC01510 suppresses cell proliferation and invasion by inhibiting Wnt/β-catenin signaling in renal cell carcinoma.
Ma B; Zhang J; Zhou W; Chu C; Zhao C; Zhang Z; Huang T
Biochem Biophys Res Commun; 2018 Oct; 505(1):7-12. PubMed ID: 30224058
[TBL] [Abstract][Full Text] [Related]
25. Exploration of the linkage elements of porcupine antagonists led to potent Wnt signaling pathway inhibitors.
Dong Y; Li K; Xu Z; Ma H; Zheng J; Hu Z; He S; Wu Y; Sun Z; Luo L; Li J; Zhang H; Zhang X
Bioorg Med Chem; 2015 Nov; 23(21):6855-68. PubMed ID: 26455655
[TBL] [Abstract][Full Text] [Related]
26. Novel PORCN inhibitor WHN-88 targets Wnt/β-catenin pathway and prevents the growth of Wnt-driven cancers.
Yang Q; Qin T; An T; Wu H; Xu G; Xiang J; Lei K; Zhang S; Xia J; Su G; Wang D; Xue M; Kong L; Zhang W; Wu S; Li Y
Eur J Pharmacol; 2023 Apr; 945():175628. PubMed ID: 36858339
[TBL] [Abstract][Full Text] [Related]
27. Porcupine inhibitors impair trabecular and cortical bone mass and strength in mice.
Funck-Brentano T; Nilsson KH; Brommage R; Henning P; Lerner UH; Koskela A; Tuukkanen J; Cohen-Solal M; Movérare-Skrtic S; Ohlsson C
J Endocrinol; 2018 Jul; 238(1):13-23. PubMed ID: 29720540
[TBL] [Abstract][Full Text] [Related]
28. BMP8A promotes survival and drug resistance via Nrf2/TRIM24 signaling pathway in clear cell renal cell carcinoma.
Yu YP; Cai LC; Wang XY; Cheng SY; Zhang DM; Jian WG; Wang TD; Yang JK; Yang KB; Zhang C
Cancer Sci; 2020 May; 111(5):1555-1566. PubMed ID: 32128917
[TBL] [Abstract][Full Text] [Related]
29. Long non-coding RNA CCAT2 promotes cell proliferation and invasion through regulating Wnt/β-catenin signaling pathway in clear cell renal cell carcinoma.
Huang JL; Liao Y; Qiu MX; Li J; An Y
Tumour Biol; 2017 Jul; 39(7):1010428317711314. PubMed ID: 28718366
[TBL] [Abstract][Full Text] [Related]
30. LPS-induced inflammatory response is suppressed by Wnt inhibitors, Dickkopf-1 and LGK974.
Jang J; Jung Y; Kim Y; Jho EH; Yoon Y
Sci Rep; 2017 Jan; 7():41612. PubMed ID: 28128299
[TBL] [Abstract][Full Text] [Related]
31. Targeting of Deregulated Wnt/β-Catenin Signaling by PRI-724 and LGK974 Inhibitors in Germ Cell Tumor Cell Lines.
Schmidtova S; Kalavska K; Liskova V; Plava J; Miklikova S; Kucerova L; Matuskova M; Rojikova L; Cierna Z; Rogozea A; Konig H; Albany C; Mego M; Chovanec M
Int J Mol Sci; 2021 Apr; 22(8):. PubMed ID: 33923996
[TBL] [Abstract][Full Text] [Related]
32. Responses of Porcupine and Wntless proteins to oxidative, hypoxic and endoplasmic reticulum stresses.
Mohamed R; Kennedy C; Willmore WG
Cell Signal; 2021 Sep; 85():110047. PubMed ID: 34015469
[TBL] [Abstract][Full Text] [Related]
33. Suppression of Wnt/β-Catenin Signaling Is Associated with Downregulation of Wnt1, PORCN, and Rspo2 in Alzheimer's Disease.
Macyczko JR; Wang N; Zhao J; Ren Y; Lu W; Ikezu TC; Zhao N; Liu CC; Bu G; Li Y
Mol Neurobiol; 2023 Jan; 60(1):26-35. PubMed ID: 36215026
[TBL] [Abstract][Full Text] [Related]
34. Kindlin‑2 promotes clear cell renal cell carcinoma progression through the Wnt signaling pathway.
Li M; Pei X; Wang G; Zhan J; Du J; Jiang H; Tang Y; Zhang H; He H
Oncol Rep; 2017 Sep; 38(3):1551-1560. PubMed ID: 28677779
[TBL] [Abstract][Full Text] [Related]
35. LINC00675 suppresses proliferative, migration and invasion of clear cell renal cell carcinoma via the Wnt/β-catenin pathway.
Zhu L; Liu XL; Fu ZQ; Qiu P; Feng T; Yan B; Wei JL
Eur Rev Med Pharmacol Sci; 2020 Mar; 24(5):2313-2320. PubMed ID: 32196582
[TBL] [Abstract][Full Text] [Related]
36. Long non-coding RNA ENST00000434223 inhibits the progression of renal cancer through Wnt/hygro-catenin signaling pathway.
Luo NQ; Ma DR; Yang XC; Liu Y; Zhou P; Guo LJ; Huang XD
Eur Rev Med Pharmacol Sci; 2019 Aug; 23(16):6868-6877. PubMed ID: 31486486
[TBL] [Abstract][Full Text] [Related]
37. Porcupine Inhibition Disrupts Mitochondrial Function and Homeostasis in WNT Ligand-Addicted Pancreatic Cancer.
Aguilera KY; Le T; Riahi R; Lay AR; Hinz S; Saadat EA; Vashisht AA; Wohlschlegel J; Donahue TR; Radu CG; Dawson DW
Mol Cancer Ther; 2022 Jun; 21(6):936-947. PubMed ID: 35313331
[TBL] [Abstract][Full Text] [Related]
38. NOTUM is a potential pharmacodynamic biomarker of Wnt pathway inhibition.
Madan B; Ke Z; Lei ZD; Oliver FA; Oshima M; Lee MA; Rozen S; Virshup DM
Oncotarget; 2016 Mar; 7(11):12386-92. PubMed ID: 26848981
[TBL] [Abstract][Full Text] [Related]
39. Divergent effects of Porcupine and Wntless on WNT1 trafficking, secretion, and signaling.
Galli LM; Zebarjadi N; Li L; Lingappa VR; Burrus LW
Exp Cell Res; 2016 Sep; 347(1):171-183. PubMed ID: 27492485
[TBL] [Abstract][Full Text] [Related]
40. Pharmacologic Wnt Inhibition Reduces Proliferation, Survival, and Clonogenicity of Glioblastoma Cells.
Kahlert UD; Suwala AK; Koch K; Natsumeda M; Orr BA; Hayashi M; Maciaczyk J; Eberhart CG
J Neuropathol Exp Neurol; 2015 Sep; 74(9):889-900. PubMed ID: 26222502
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
